FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081210 [Registered on: 24/02/2025] Trial Registered Prospectively
Last Modified On: 25/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   The incidence and risk factors of post operative confusion in head neck cancer surgical patients 
Scientific Title of Study   Incidence of delirium and postoperative outcomes in head neck cancer surgical patients- A prospective observational study 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Malini Joshi 
Designation  Professor, Department of Anaesthesia, Critical Care and Pain, ACTREC, Tata Memorial Centre 
Affiliation  Tata Memorial Centre 
Address  ACTREC, Tata Memorial Centre, Sector 22, Kharghar, Navi Mumbai Address Mumbai MAHARASHTRA 410210 India

Mumbai
MAHARASHTRA
410210
India 
Phone  9987226657  
Fax    
Email  jmalini2007@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Malini Joshi 
Designation  Professor, Department of Anaesthesia, Critical Care and Pain, ACTREC, Tata Memorial Centre 
Affiliation  Tata Memorial Centre 
Address  ACTREC, Tata Memorial Centre, Sector 22, Kharghar, Navi Mumbai Address Mumbai MAHARASHTRA 410210 India


MAHARASHTRA
410210
India 
Phone  9987226657  
Fax    
Email  jmalini2007@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Athira Celine Justine 
Designation  Junior Resident, Department of Anaesthesia, Critical Care and Pain, Tata Memorial Centre 
Affiliation  Tata Memorial Centre 
Address  Dept of Anaesthesiology, Critical Care and Pain, 7th floor, Rajarao Shodhika Building, ACTREC, Tata Memorial Centre, Sector 22, Kharghar, Navi Mumbai Address Mumbai MAHARASHTRA 410210 India

Mumbai
MAHARASHTRA
410210
India 
Phone  7639412964  
Fax    
Email  athira.justine98@gmail.com  
 
Source of Monetary or Material Support  
Not applicable 
 
Primary Sponsor  
Name  ACTREC Tata Memorial Centre 
Address  ACTREC Tata Memorial Centre, Sector 22, Kharghar Navi Mumbai 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shilpushp Bhosale  Tata Memorial Centre  Dept of Anaesthesiology, Critical Care and Pain, 7th floor, Rajarao Shodhika Building, ACTREC, Tata Memorial Centre, Sector 22, Kharghar, Navi Mumbai Mumbai MAHARASHTRA
Mumbai
MAHARASHTRA 
9619310657

shilbhosale@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ACTREC, Institutional Ethical Committee 3  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  All adult postoperative head neck patients admitted to recovery room or ICU for more than 24 hrs 
 
ExclusionCriteria 
Details  Patients with prior psychiatric illness or patients on medications that will influence delirium 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Study the incidence of Delirium in postoperative adult head and neck surgical patients
2. To evaluate the impact of delirium on various post-operative outcome, including: Length of hospital stay, rate of complication (e.g. Infection, respiratory issues), need for additional interventional (e.g. Reoperation)
3. Risk factor identification: identify risk factors for developing delirium, such as age, comorbidity, medication use, and surgical complexity. 
Data will be collected over a period of 1 year 
 
Secondary Outcome  
Outcome  TimePoints 
1. 30-day Clavien Dindo complication rate
2. ICU & Hospital length of stay & outcomes
 
Data will be collected over a period of 1 year 
 
Target Sample Size   Total Sample Size="1200"
Sample Size from India="1200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patients undergoing major head and neck onco-surgeries can have significant postoperative morbidity. Delirium, a neuropsychiatric syndrome, is definedas a disturbance in attention, awareness, and cognition that develops over a short period oftime and fluctuates in severity. It is transient and usually reversible. Delirium in critically care population is reported between 20 to 40%. It can be either hyperactive, hypoactive or mixed type. It is important to assess delirium as it can have negative impact on the outcome and recovery from critical illness. We are using the CAM-ICU score to detect delirium in out population. We will study the incidence of delirium, the impact in post op outcome and risk factors associated with it. The data will be collected over a period of 1 year in ACTREC, Tata Memorial Centre. The data will be collected from the case record form and there will be no direct patient contact. Data will be maintained securely and will not be disclosed at any point during the study.  
Close